Supplementary Figure 3 from HER2 Overexpression Renders Human Breast Cancers Sensitive to PARP Inhibition Independently of Any Defect in Homologous Recombination DNA Repair

PDF file - 62K, MCF7 HER2 cells but not its isogenic MCF7 NEO controls are susceptible to the PARP inhibitors ABT-888 and AZD-2281